UniProt Q9BZ95
Histone-lysine N-methyltransferase NSD3 (Q9BZ95)
Histone-lysine N-methyltransferase NSD3 (UniProt Q9BZ95), EC 2.1.1.-, 2.1.1.43: 41 experimental structures and 1 predicted model on GenesisL1, 14 ligands bound, 26 pockets. Binding sites, druggability and experiment against…
- UniProt
- Q9BZ95
- Protein
- Histone-lysine N-methyltransferase NSD3
- EC
- 2.1.1.-, 2.1.1.43
- Experimental structures
- 41
- Predicted models
- 1
- Ligands
- 14
- Pockets
- 26 · 2 records with a druggable one
Structures
42 records of Q9BZ95 in the MolNFT archive: 41 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2DAQ | Solution structure of second PWWP domain of WHSC1L1 protein | solution nmr | A | — | — |
| 2DAQ | Solution structure of second pwwp domain of WHSC1L1 protein | solution nmr | A | — | — |
| 2NCZ | Solution NMR structures of BRD4 ET domain in complex with NSD3_1 peptide | solution nmr | B | — | — |
| 2NCZ | Solution NMR structures of BRD4 et domain in complex with NSD3_1 peptide | solution nmr | B | — | — |
| 2ND1 | Solution NMR structures of BRD4 ET domain in complex with NSD3_3 peptide | solution nmr | B | — | — |
| 2ND1 | Solution NMR structures of BRD4 et domain in complex with NSD3_3 peptide | solution nmr | B | — | — |
| 4GND | Crystal Structure of NSD3 tandem PHD5-C5HCH domains | x-ray diffraction | A, C | — | — |
| 4GND | Crystal structure of NSD3 tandem PHD5-C5HCH domains | x-ray diffraction | A, C | — | — |
| 4GNE | Crystal Structure of NSD3 tandem PHD5-C5HCH domains complexed with H3 peptide 1-7 | x-ray diffraction | A | — | — |
| 4GNE | Crystal structure of NSD3 tandem PHD5-C5HCH domains complexed with H3 peptide 1-7 | x-ray diffraction | A | — | — |
| 4GNF | Crystal Structure of NSD3 tandem PHD5-C5HCH domains complexed with H3 peptide 1-15 | x-ray diffraction | A | — | — |
| 4GNF | Crystal structure of NSD3 tandem PHD5-C5HCH domains complexed with H3 peptide 1-15 | x-ray diffraction | A | — | — |
| 4GNG | Crystal Structure of NSD3 tandem PHD5-C5HCH domains complexed with H3K9me3 peptide | x-ray diffraction | A, D | — | — |
| 4GNG | Crystal structure of NSD3 tandem PHD5-C5HCH domains complexed with H3K9ME3 peptide | x-ray diffraction | A, D | — | — |
| 4RXJ | crystal structure of WHSC1L1-PWWP2 | x-ray diffraction | A | — | — |
| 4RXJ | Crystal structure of WHSC1L1-PWWP2 | x-ray diffraction | A | — | — |
| 5UPD | Methyltransferase domain of human wolf-hirschhorn syndrome candidate 1-like protein 1 (WHSC1L1) | x-ray diffraction | A | UNX, ZN | — |
| 6CEN | Crystal Structure of WHSC1L1 in Complex with Inhibitor PEP21 | x-ray diffraction | A | ZN | — |
| 6CEN | Crystal structure of WHSC1L1 in complex with inhibitor PEP21 | x-ray diffraction | A | ACE, NH2, ZN | — |
| 6G24 | X-ray structure of NSD3-PWWP1 in complex with compound 3 | x-ray diffraction | A | EH2 | 2 (best 0.36) |
| 6G24 | X-ray structure of NSD3-PWWP1 in complex with compound 3 | x-ray diffraction | A | EH2 | — |
| 6G25 | X-ray structure of NSD3-PWWP1 in complex with compound 4 | x-ray diffraction | A | EHQ | 2 (best 0.42) |
| 6G25 | X-ray structure of NSD3-PWWP1 in complex with compound 4 | x-ray diffraction | A | EHQ | — |
| 6G27 | X-ray structure of NSD3-PWWP1 in complex with compound 5 | x-ray diffraction | A | EHE | — |
| 6G29 | X-ray structure of NSD3-PWWP1 in complex with compound 6 | x-ray diffraction | A | EHK | 1 (best 0.41) |
| 6G29 | X-ray structure of NSD3-PWWP1 in complex with compound 6 | x-ray diffraction | A | EHK | — |
| 6G2B | X-ray structure of NSD3-PWWP1 in complex with compound 8 | x-ray diffraction | A | EH8 | 2 (best 0.41) |
| 6G2B | X-ray structure of NSD3-PWWP1 in complex with compound 8 | x-ray diffraction | A | EH8 | — |
| 6G2C | X-ray structure of NSD3-PWWP1 in complex with compound 9 | x-ray diffraction | A | EHT | — |
| 6G2E | X-ray structure of NSD3-PWWP1 in complex with compound 13 | x-ray diffraction | A | EHH | 2 (best 0.41) |
| 6G2E | X-ray structure of NSD3-PWWP1 in complex with compound 13 | x-ray diffraction | A | EHH | — |
| 6G2F | X-ray structure of NSD3-PWWP1 in complex with compound 16 | x-ray diffraction | A | EHW | — |
| 6G2O | X-ray structure of NSD3-PWWP1 in complex with compound BI-9321 | x-ray diffraction | A | EJE | 1 (best 0.44) |
| 6G2O | X-ray structure of NSD3-PWWP1 in complex with compound bi-9321 | x-ray diffraction | A | EJE | — |
| 6G3P | X-ray structure of seleno-methionine labelled NSD3-PWWP1 | x-ray diffraction | A, B, C, D | — | — |
| 6G3T | X-ray structure of NSD3-PWWP1 | x-ray diffraction | A, B, C, D | — | — |
| 7CRP | NSD3 bearing E1181K/T1232A dual mutation in complex with 187-bp ncp (1:1 binding mode) | electron microscopy | I | ZN | — |
| 7CRQ | NSD3 bearing E1181K/T1232A dual mutation in complex with 187-bp ncp (2:1 binding mode) | electron microscopy | I, L | ZN | — |
| 7CRR | Native NSD3 bound to 187-bp nucleosome | electron microscopy | I | SAM, ZN | 3 (best 0.72) |
| 7CRR | Native NSD3 bound to 187-bp nucleosome | electron microscopy | I | ZN | — |
| 7JYN | Solution NMR structure of human BRD3 et complexed with NSD3(148-184) peptide | solution nmr | B | — | — |
| Q9BZ95 | AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase NSD3 (Q9BZ95) | predicted | A | — | 13 (best 0.75) |
Ligands
- ZN · Zinc ion · in 7 records
- EH2 · 2-[(~{E})-2-thiophen-2-ylethenyl]benzoic acid · in 2 records
- EH8 · 4-(3-methyl-5-phenyl-imidazol-4-yl)pyridine · in 2 records
- EHH · [3,5-dimethyl-4-(1-methyl-5-pyridin-4-yl-imidazol-4-yl)phenyl]methanamine · in 2 records
- EHK · 5-methyl-2-piperidin-4-yl-6-pyridin-4-yl-pyridazin-3-one · in 2 records
- EHQ · 3,5-dimethyl-4-(4-pyridin-4-yl-1~{H}-pyrazol-3-yl)-1,2-oxazole · in 2 records
- EJE · [4-[5-(7-fluoranylquinolin-4-yl)-1-methyl-imidazol-4-yl]-3,5-dimethyl-phenyl]methanamine · in 2 records
- ACE · Acetyl group · in 1 record
- EHE · 5-methyl-6-phenyl-2-piperidin-4-yl-pyridazin-3-one · in 1 record
- EHT · 3,5-dimethyl-4-(1-methyl-5-pyridin-4-yl-imidazol-4-yl)-1,2-oxazole · in 1 record
- EHW · 4-[5-(7-fluoranylquinolin-4-yl)-1-methyl-imidazol-4-yl]-3,5-dimethyl-1,2-oxazole · in 1 record
- NH2 · Amino group · in 1 record
- SAM · S-adenosylmethionine · in 1 record
- UNX · Unknown atom or ion · in 1 record
Experiment against prediction
- 5UPD chain A against the predicted model Q9BZ95: TM-score 0.98, RMSD 0.84 Å
- 4GNF chain A against the predicted model Q9BZ95: TM-score 0.98, RMSD 0.59 Å
- 4GNF chain A against the predicted model Q9BZ95: TM-score 0.98, RMSD 0.59 Å
- 6G3T chain B against the predicted model Q9BZ95: TM-score 0.96, RMSD 0.86 Å
- 6G3T chain D against the predicted model Q9BZ95: TM-score 0.96, RMSD 0.86 Å
- 6G3T chain C against the predicted model Q9BZ95: TM-score 0.96, RMSD 0.86 Å
- 6G3P chain D against the predicted model Q9BZ95: TM-score 0.96, RMSD 0.84 Å
- 6G3T chain A against the predicted model Q9BZ95: TM-score 0.96, RMSD 0.88 Å
- 6G2E chain A against the predicted model Q9BZ95: TM-score 0.96, RMSD 1.12 Å
- 6G2E chain A against the predicted model Q9BZ95: TM-score 0.96, RMSD 1.12 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.